EMEA-000057-PIP01-07-M05

Key facts

Invented name
Aclasta
Active substance
zoledronic acid
Therapeutic area
Other
Decision number
P/0140/2013
PIP number
EMEA-000057-PIP01-07-M05
Pharmaceutical form(s)
Solution for infusion
Condition(s) / indication(s)
  • Paget's disease of the bone
  • Osteoporosis
Route(s) of administration
Intravenous use
Contact for public enquiries
Novartis Europharm Limited
E-mail: paediatric.enquiries@novartis.com
United Kingdom
Tel. +41 61 324 1111
 
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating